These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3718405)

  • 21. An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition.
    Demers C; Henderson P; Blajchman MA; Wells MJ; Mitchell L; Johnston M; Ofosu FA; Fernandez-Rachubinski F; Andrew M; Hirsh J
    Thromb Haemost; 1993 Mar; 69(3):231-5. PubMed ID: 8470046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
    Pieters J; Willems G; Hemker HC; Lindhout T
    J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
    Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
    Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous isolation and partial characterization of antithrombin III and alpha 1-proteinase inhibitor from horse plasma.
    Kurdowska A; Koj A; Jaśkowska M
    Acta Biochim Pol; 1982; 29(1-2):95-103. PubMed ID: 6983800
    [No Abstract]   [Full Text] [Related]  

  • 28. Isolation of plasma proteins from the clotting cascade by heparin affinity chromatography.
    Josić D; Bal F; Schwinn H
    J Chromatogr; 1993 Feb; 632(1-2):1-10. PubMed ID: 8454710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of antithrombin III from normal and alpha1-antitrypsin-deficient human plasma.
    Borsodi AD; Bradshaw RA
    Thromb Haemost; 1977 Aug; 38(2):475-85. PubMed ID: 304258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithrombin III Toyama: a congenital antithrombin III abnormality with recurrent thrombophlebitis.
    Takahashi K; Kondo S; Sakuragawa N
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1895-905. PubMed ID: 3836552
    [No Abstract]   [Full Text] [Related]  

  • 31. Purification and characterization of guinea pig antithrombin III.
    Clement LT
    Prep Biochem; 1983; 13(1):1-20. PubMed ID: 6856582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of the cultivation process of antithrombin III and its characterization by capillary electrophoresis.
    Reif OW; Freitag R
    J Chromatogr A; 1994 Oct; 680(2):383-94. PubMed ID: 7981822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the biological activity of antithrombin III in patients with hepatic cirrhosis.
    Matsuo T; Matsuo C; Matsuo O
    Clin Chim Acta; 1984 Jul; 140(2):125-32. PubMed ID: 6467606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolation and characteristics of antithrombin III from human plasma].
    Markova OA; Kalashnikov VV; Khvatov VB
    Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human factor Xa by various plasma protease inhibitors.
    Ellis V; Scully M; MacGregor I; Kakkar V
    Biochim Biophys Acta; 1982 Feb; 701(1):24-31. PubMed ID: 6173074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and characterization of rat plasma antithrombin III.
    Takahara H; Sinohara H
    Biochim Biophys Acta; 1980 Mar; 612(1):185-94. PubMed ID: 7362830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
    Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
    Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Hereditary Thrombophilia: Performance of Antithrombin (AT) Testing.
    Gausman JN; Marlar RA
    Methods Mol Biol; 2017; 1646():161-167. PubMed ID: 28804827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of rat factors X and Xa: demonstration of factor Xa in rat plasma.
    Enjyoji K; Miyazaki K; Kato H
    J Biochem; 1991 Jun; 109(6):890-8. PubMed ID: 1718949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated clotting factors in factor IX concentrates.
    Hultin MB
    Blood; 1979 Nov; 54(5):1028-38. PubMed ID: 497395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.